medRxiv preprint doi: https://doi.org/10.1101/2020.08.02.20129767; this version posted August 10, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

A Classification Approach for Predicting COVID-19 Patientâ€™s
Survival Outcome with Machine Learning Techniques
Abdulhameed Ado Osi1*Â¶, Mannir Abdu1Â§, Usman Muhammad3Â§, Auwalu Ibrahim1Â§, Lawan Adamu
Ismaâ€™il1Â§, Ahmad Abubakar Suleiman1Â§, Hasssan Sarki Abdulkadir1Â§ Safiya Sani Sada4Â§, Hussaini Garba
Dikko2Â§ and Muftahu Zubairu Ringim2

1

Department of Statistics, Kano University of Science and Technology, Wudil, Nigeria.
Department of Mathematics, Kano University of Science and Technology, Wudil, Nigeria.
3
Department of Statistics, Ahmadu Bello University, Zaria, Nigeria
4
Department. of Agronomy, Ahmadu Bello University, Zaria, Nigeria.
aaosi@kustwudil.edu.ng +2348069120811
2

* Corresponding author
abuammarosi@gmail.com; aaosi@kustwudil.edu.ng (AAO) +2348069120811

Â¶

This author is first author

Â§

These authors contributed equally to this work

NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.

medRxiv preprint doi: https://doi.org/10.1101/2020.08.02.20129767; this version posted August 10, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Abstract
COVID-19 is an infectious disease discovered after the outbreak began in Wuhan, China, in December
2019. COVID-19 is still becoming an increasing global threat to public health. The virus has been
escalated to many countries across the globe. This paper analyzed and compared the performance of three
different supervised machine learning techniques; Linear Discriminant Analysis (LDA), Random Forest
(RF), and Support Vector Machine (SVM) on COVID-19 dataset. The best level of accuracy between
these three algorithms was determined by comparison of some metrics for assessing predictive
performance such as accuracy, sensitivity, specificity, F-score, Kappa index, and ROC. From the analysis
results, RF was found to be the best algorithm with 100% prediction accuracy in comparison with LDA
and SVM with 95.2% and 90.9% respectively. Our analysis shows that out of these three classification
models RF predicts COVID-19 patient's survival outcome with the highest accuracy. Chi-square test
reveals that all the seven features except sex were significantly correlated with the COVID-19 patient's
outcome (P-value < 0.005). Therefore, RF was recommended for COVID-19 patientâ€™s outcome prediction
that will help in early identification of possible sensitive cases for quick provision of quality health care,
support and supervision.

Key Words: COVID-19, Survival outcomes, Random Forest, Linear Discriminant Analysis, Support Vector
Machine

1. Introduction
In December, 2019 an outbreak of pneumonia of unknown cause emerged in Wuhan, Hubei
Province, China that led to the discovery of coronavirus. Since then, the disease has been spreading rapidly
to more than 150 countries across the globe with more than 3,132,000 confirmed cases of infection and
about 230,000 deaths as at 30th April,2020 [1]. In February 2020 the World health organization termed
this newly discovered disease as COVID-19 (coronavirus 2019) and subsequently declared it as pandemic
on 12th March, 2020 [2]. COVID-19 also known as Severe Acute Respiratory Syndrome Coronavirus 2
(SARS-CoV-2) is a communicable disease that cause respiratory infection that is generally similar to
Severe Acute Respiratory Syndrome (SARS-CoV) and Middle East Respiratory Syndrome (MERS-CoV)
in severe cases. The disease can be transmitted from person to person via a droplets coming out from the
mouth or nose of infected person. The most common symptoms of COVID-19 are: fever; fatigue and dry
cough [3]. Some patients may have sore throat, diarrhea, headache and nasal congestion. However, most
COVID-19 patients donâ€™t develop any symptoms (asymptotic).

medRxiv preprint doi: https://doi.org/10.1101/2020.08.02.20129767; this version posted August 10, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Current studies have shown that most of the COVID-19 patients with underline comorbidity and
elderly patients are more likely to develop severe cases which may require ICU care and could lead to
death [4]. Several existing literature reported diabetes and hypertension as the most common
comorbidities for people with COVID-19 [3] [5] [4] [6]. Although, clinical results showed that being
diabetic or hypertensive has no association with the risk of contracting the diseases [7]. However, it could
increase chances for severe and critical COVID-19 conditions [8] [3].
Currently, the ongoing pandemic (COVID-19) has attracted the interest of many researchers.
Different statistical models have been used in many studies to predict COVID-19 cases, prevalence and
mortality [9]used Multivariate Logistic Regression to determine the risk factor associated with mortality,
[3] used Cox Regression Models to explore potential risk factors associated with clinical outcomes, While
[10] applied Chi-square Test and Spearmanâ€™s Ranked Correlation to explored the significant differences
between severe and non-severe COVID-19 cases using the clinical and laboratory characteristic of
hospitalized patients. [11] used the Mann Whitney U test or Kruskal-Wallis test for comparison
significance differences for univariate and chi-square for categorical variables, and then modeled patientâ€™s
survival with Hierarchical Cox Regression to identify poor outcome risk population. [12] applied Chisquare to test the association between being HFABP positive and COVID-19 severity using
epidemiological, clinical, and laboratory characteristics.
Machine Learning is modern data analysis technique deals with patterns and correlations to extract
useful information from the raw data. Machine Learning played a significant role in fighting the previous
epidemic, more especially in the area of the disease diagnosis, medication, prediction and drug/vaccine
development [13]. Numerous Machine Learning Algorithms have shown powerful prediction capabilities
in the diseases prediction [14] [15] [16] [17]. Machine learning technique has recently gained attention
for the COVID-19 outbreak spreading prediction [18].. There is gap in the literature for studies dedicated
to COVID-19, most of the existing studies are limited to cases prediction. This study focuses on the
application of supervised machine learning techniques (i.e SM, RF, LDA) to predict the survival outcome

medRxiv preprint doi: https://doi.org/10.1101/2020.08.02.20129767; this version posted August 10, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

of COVID-19 patients based on some demographic, clinical and epidemiological characteristics. Also to
assess the performance of the methods using seven different metrics. The paper equally investigates the
effect of these demographics and clinical variables to the patientâ€™s outcome.

2. Material and Methods
2.1

Dataset and variables
This study uses detail information of patientsâ€™ demographic, epidemiological, clinical

characteristics (including age, sex, comorbidities, hospital length of stay, travel history, signs, and
symptoms),

and

their

definite

survival

outcomes

(discharge

or

death)

available

at

https://drive.google.com/file/d/1bYcMAd-lOiSlOVGl5qxG1Sq1auyzmWHZ/view . A total sample of
425 confirmed of COVID-19 patients were extracted and who were died or discharged on or before 11th
March, 2020 were included in the study. This study was approved by the General Research Ethics
Committee of the Kano University of Science and Technology, Wudil, Nigeria. The data were partitioned
into two parts (training and test data set), the first part (80%) was used to develop the learning algorithms
while the second part (20%) to test the performances of the algorithms.

2.2

Prediction models
Three different types of classification models: Linear Discriminant Analysis (LDA), Random

Forest (RF), and Support Vector Machines (SVM) were used. These methods have been widely reported
and demonstrated as successful methods for classification [17]. Description of each of these classification
models is given below.

2.2.1 Linear Discriminant Analysis
Discriminant Analysis (DA) find a set of prediction equation based on independent variables that
are used to classify individuals. The main objectives of DA are to find a predictive equation for classifying
new individuals and interpreting the predictive equation for a better understanding of the relationship
among the variables.

medRxiv preprint doi: https://doi.org/10.1101/2020.08.02.20129767; this version posted August 10, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Linear Discriminant Analysis (LDA) formulated by [19] is most commonly used DA. The original
Linear Discriminant Analysis was described for a 2-class problem,, and it was later generalized to multiple
class by [20]. LDA makes some assumptions about the dataset: the data is Gaussian, and each

attribute has the same variance.
LDA use of Bayes theorem to construct the decision rule. Let ðœ‹ð‘˜ represent the prior
probability of kth class, and let ð‘“ð‘˜ (ð‘‹) â‰¡ Prâ¡(ð‘‹ = ð‘¥|ð‘Œ = ð‘˜) denote a conditional density of X
given that the observation comes from kth class. The posterior probability is given as
ðœ‹ ð‘“ (ð‘‹)

ð‘ƒ(ð‘Œ = ð‘˜ |ð‘‹ = ð‘¥) = âˆ‘ð¾ ð‘˜ ðœ‹ð‘˜ð‘“ (ð‘‹)
ð‘™=1 ð‘™ ð‘™

(1)

By the two LDA assumptions
ð‘“ð‘˜ (ð‘‹) =

1
1
1
(2ðœ‹) â„2|Î£ð‘˜ | â„2

1â„ (ð‘¥âˆ’ðœ‡)ð‘‡ Î£ âˆ’1 (ð‘¥âˆ’ðœ‡)
ð‘˜
2

ð‘’âˆ’

(2)

Where Î£ð‘˜ = Î£â¡â¡âˆ€ð‘˜
The decision rule is to assign an observation X=x to the class for which
1

ð›¿ð‘˜ (ð‘¥) = ð‘¥ ð‘‡ Î£â¡âˆ’1 ðœ‡ð‘˜ âˆ’ 2 ðœ‡ð‘˜ð‘‡ Î£â¡âˆ’1 ðœ‡ð‘˜ + logâ¡(ðœ‹ð‘˜ ) is largest.

2.2.2

(3)

Support Vector Machine.

The Support Vector Machine (SVM) is a powerful technique for general (nonlinear supervised machine
learning algorithm that is suitable for linear and non-linear problems and can be used for both regression
and classification. The aim of SVM is to find a hyperplane in a multidimensional space that splits the
feature space into two distinct groups. A new subject is then classified based on which side of the
hyperplane he lies on. SVM uses kernel function to converts non-separable problems into separable

problems by mapping the training data into higher-dimensional feature space, then finds the hyperplane
that maximizes the distance from the nearest subjects and achieves maximum separation. The kernel
function can be linear, polynomial or radial, and the choice of the kernel can have a large effect on model

medRxiv preprint doi: https://doi.org/10.1101/2020.08.02.20129767; this version posted August 10, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

outputs. SVM method has successfully achieved high predictive performance in health care researches. In
this study, we implemented SVM using the â€œe1071â€ package in the R statistical environment.
2.2.3

Random forest.
Random Forests (RF) developed by [21] are among the most widely used machine learning

algorithm. In RF a "forest" of decision trees are generated on different bootstrap samples by re-sampling
the training data that limit. for each single decision tree a random subset of features is randomly chosen
at each node to decide optimal split. For classification problems, the ensemble of simple trees votes for
the most popular class. The response of each tree depends on a set of predictor values chosen
independently (with replacement) and with the same distribution for all trees in the forest, which is a
subset of the predictor values of the original data set. The Random Forest has two important parameters ,
the number of predictive variables to randomly choose at each node for splitting (mtry) and the number
of trees to grow in the forest (ntree) [21]. In this study we used the R package â€œrandomForestâ€, with 1000
trees and mtry = 3, which is square root of the total number of predictor variables.

2.3

Performance evaluation for the classification methods
Model performance evaluation is a core part of constructing effective machine learning model.

The evaluation can be performed with a set of performance measure metrics, most of whom are derived
from confusion matrix. The confusion matrix compares the original (observed) class with predicted class.
It consists of four possible outcomes; TP stands for true positives TN (true negatives), FP (false positives),
and FN (false negatives). TP and TN are representing a situation whereby the classifier correctly classified
positive and negative (â€œDiedâ€ and â€œDischargedâ€ in our case) instances respectively. FP denotes number
of cases where the model misclassified positive as negative while FN represents patients negative
incorrectly classified as positive. Table 1 shows layout of the confusion matrix.
Table1: Confusion matrix
Predicted

medRxiv preprint doi: https://doi.org/10.1101/2020.08.02.20129767; this version posted August 10, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Observed

P

N

P

TP

FN

N

FP

TN

Generally, there is no universally accepted metric for measuring classifiers performance. However,
the choice of metric depends on the application. Care need to be taken on how choose the evaluation
metrics as it is obvious that, at the same time a classifier could perform very well on a particular metric
and badly on the another. Therefore, correct selection of performance metrics is essential to achieve
reliable results. [22] suggested that, a classifier should be evaluated using set of performance metrics that
ate not closely related to reduce redundancy. In this study, we employed seven most commonly evaluation
metrics of two different types; threshold metric (precision, accuracy, sensitivity, specificity, F-score and
kappa) and rank metric(AUC-ROC). The metrics are defined below.
i.

Accuracy: Accuracy is a widely used metric for monitoring machine learning models
performance and defines as the ration of the correctly classified instances to total number of
instances, for unbalanced data this metric can be misleading.
ð‘‡ð‘ƒ+ð‘‡ð‘

ð´ð‘ð‘ð‘¢ð‘Ÿð‘Žð‘ð‘¦ = ð‘‡ð‘+ð¹ð‘ƒ+ð¹ð‘+ð‘‡ð‘ƒ
ii.

(6)

F- score: The F-score is a single-value metric based on two parameters. It is weighted average
of the precision and recall values. In other word, is the harmonic mean of the precision and
recall. The range of F-score is between 0 and 1 (1 means perfect).

ð¹ âˆ’ ð‘ ð‘ð‘œð‘Ÿð‘’ =
iii.

2âˆ—ð‘…ð‘’ð‘ð‘Žð‘™ð‘™âˆ—ð‘ƒð‘Ÿð‘’ð‘ð‘–ð‘ ð‘–ð‘œð‘›
ð‘…ð‘’ð‘ð‘Žð‘™ð‘™+ð‘ƒð‘Ÿð‘’ð‘ð‘–ð‘ ð‘–ð‘œð‘›

=

2.ð‘‡ð‘ƒ
2.ð‘‡ð‘ƒ+ð¹ð‘ƒ+ð¹ð‘

(4)

Kappa: Kappa is a coefficient developed to measure observed agreement normalized to the
agreement by chance.

medRxiv preprint doi: https://doi.org/10.1101/2020.08.02.20129767; this version posted August 10, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

ð¾=
iv.

ð‘ƒð‘œð‘ð‘  âˆ’ð‘ƒð‘â„Žð‘Žð‘›ð‘ð‘’

(5)

1âˆ’ð‘ƒð‘â„Žð‘Žð‘›ð‘ð‘’

Sensitivity/Recall: Sensitivity is defined as the proportion of positive instances that are
correctly classified as positive, with respect to all positive set.
ð‘‡ð‘ƒ

ð‘†ð‘’ð‘›ð‘ ð‘–ð‘¡ð‘–ð‘£ð‘–ð‘¡ð‘¦/ð‘…ð‘’ð‘ð‘Žð‘™ð‘™ = ð‘‡ð‘ƒ+ð¹ð‘
v.

(6)

Specificity: Specificity is the proportion negative instances that are correctly identified as
negative out of the total observed negative instances
ð‘‡ð‘

ð‘†ð‘ð‘’ð‘ð‘–ð‘“ð‘–ð‘ð‘–ð‘¡ð‘¦ = â¡ ð‘‡ð‘+ð¹ð‘ƒ
vi.

(7)

Precision: Precision is the true positive divided by the sum of all positive prediction

ð‘‡ð‘ƒ

ð‘ƒð‘Ÿð‘’ð‘ð‘–ð‘ ð‘–ð‘œð‘› = ð‘‡ð‘ƒ+ð¹ð‘ƒ
vii.

(8)

ROC-AUC: An ROC stands for Receiver Operating Characteristics is graphical plot illustrate
binary classifier performance for various thresholds. ROC is created by plotting the true
positive rate (TPR) against the false positive rate (FPR) at various threshold settings [23]. The
area under the ROC curve (AUC) summarized the ROC performance to single value, it ranged
between 0 and 1. A higher AUC value represents the superiority of a classifier and vice versa
[14]

3. Results
The mean age of the patients was 53.1 years old (the median was 54) and majority (61.2%) of
them were male Overall, 38.4% (163) of patients were died and 61.6% (262) discharged alive.
Table 2: Distribution of demographic and clinical characteristics of COVID-19 patients with the survival
outcome
Demographics and clinical Variables
0-19 years
Age group
20-39 years
40-59 years
60-79
80+ years

Total
14 (3.3%)
121 (28.5)
117 (27.5)
121 (28.5)
52 (12.2)

Died (n =163)
0
3 (0.7)
27 (6.4)
83 (19.6)
50 (11.8)

Discharged (n=262)
14 (3.3)
118 (27.8)
90 (21.2)
28 (8.9)
2 (0.5)

P-value
0.000

medRxiv preprint doi: https://doi.org/10.1101/2020.08.02.20129767; this version posted August 10, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Female
Male

Sex
Symptoms

arrhythmia
acute respiratory distress
arrhythmia
cough & fever
diarrhea
difficulty breathing
discomfort
dry cough
fever & fatigue
myelofibrosis

Travel history
Comorbidity
(binary)
Comorbidity

LOS

pneumonia
respiratory symptoms
sore throat
NONE
NO
YES
NO
YES
Asthma
cardiac disease
chronic kidney disease
COPD
diabetes
hepatitis B
hypertension
prostate cancer
prostate hypertrophy
pulmonary disease
NONE
Above
Below

165 (38.5)
260 (61.2)
1 (1.2)
50 (11.8)
4 (0.9)

60 (36.4)
103 (39.6)
1 (100)
50 (100)
4 (100)

105 (63.6)
157 (60.4)
0
0
0

28 (6.6)
2 (0.5)
2 (0.5)
2 (0.5)
1 (0.2)
27 (6.4)
1 (0.2)

6 (21.4)
0
2 (100)
0
1 (100)
9 (33.3)
1 (100)

22 (78.6)
2 (100)
0
2 (100)
0
18 (66.7)
0

25 (5.9)
2 (0.5)
2 (0.5)
278 (63.4)
333 (78.4)
92 (21.6)
317 (74.5)
108 (25.4)
5 (1.2)
1 (0.2)
7 (1.6)
2 (0.5)
22 (5.2)
2(0.5)
61 (14.4)
2 (0.5)
2 (0.5)
2 (0.5)
319 (75.1)
186 (43.8)
239 (56.2)

25 (100)
0
1(50)
63 (22.7)
157 (47.1)
6 (6.5)
75 (23.7)
88 (81.5)
2 (40)
1 (100)
7 (100)
0
22 (100)
2 (100)
49 (80.3)
2 (100)
0
2 (100)
76 (23.8)
6 (3.2)
157 (65.7)

0
2 (100)
1 (50)
215 (77.3)
176 (52.9)
86 (96.5)
242 (76.3)
20 (18.5)
3 (60)
0
0
2 (100)
0
0
12 (19.7)
0
2 (100)
0
243 (76.2)
180 (96.8)
82 (34.3)

0.502
0.000

0.000
0.000
0.000

0.000

As shown in Table 2 above and visualized in Fig.1 below, 3.3% (14) of the patients were less than
20 years of age and all of them survived the disease, 28.5% (121) aged between 20 to 39 and 27.8% (118)
of them discharged alive, 27.5% (117) were between 40 to 59 years old of which 76.9% (90) of them
discharged from hospital, 28.5% (121) of the patients were within 60 to 79 years of age and only 31,4%
(38) of them survived, lastly 12.2% (52) of the patients aged 80 years and above of which 96.2% (50) of
them died for COVID-19. The result for test of significant difference between age group and survival
outcome, indicates p-value =0.000 (<0.05). Hence, the null hypothesis is rejected and conclude that the
two variables (age and patientsâ€™ survival outcome) relate to each other (dependent). As for distribution of
the sex of the patients, 33.8% of the patients were female and 63.5% of them were discharged while 60.4%
of the male survived. The chi-square test result for Sex and patientâ€™s outcome has P-value = 0.5690 (>
0.05) which indicates the two variables are in fact independent.

medRxiv preprint doi: https://doi.org/10.1101/2020.08.02.20129767; this version posted August 10, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Symptoms of the patients on admission as shown in Table 2, 63.4% (278/425) of the patient are
asymptotic while 147 have shown at least one symptoms and the most commonly experienced symptoms
were acute respiratory distress 34%(50/147) followed by cough & fever 19.1% (28/147), and fever &
fatigue 18.4%(27/147). On the relationship between onset symptoms and survival status, 77.3% (215) of
patients reported no symptoms on admission survived the disease. All patients with acute respiratory
symptoms died and more than 70% of patients with onset fever were discharged. A similar result was
illustrated in Fig. 2. The associativity test between symptoms and survival outcome result has P-value =
0.000 (P<0.05) hence, the two variables are statistically significantly related.
The distribution of travel history and survival status of COVID-!19 patients are as follows. 78.4%
of the patient has no travel history and 52,9% of them discharged. The mortality rate of a patient with
travel history is 6.5%. the chi-square result showed the emergence of a significant association between
travel history and survival outcome with p-value <0.05.
The comorbidity was in this case treated as binary (YES versus NO) before subsequently, grouped
based on specific comorbidity. [3] point out that both the dummy variable and specific comorbidity could
be simultaneously used in predicting COVID-19 patientsâ€™ survival outcome.

Results from cross-

tabulation indicates 25.4% of the patients under study have a history of underline medical problems of
whom only 18.5% of them survived and 81.5% were died which indicates very high mortality rate of
patients with comorbidity. The associativity test of chi-square reveals dependency between Chronic
diseases and survival outcome (P-value=0.000) and Fig.3 explains further the nature of associativity, as
we can see having comorbidity (YES) is inversely associated with "Discharged" and positively correlated
with "Death". This means those with comorbidity diseases are more likely to die with COVID-19 while
those without it have a higher chance of recovering from the disease.
Table 2 also expressed the distribution of specific comorbidities recorded on admission. 106
(24.1%) patients had at least one underlying comorbidity, the most frequent of which were chronic
diseases, such as hypertension (57.5%) and diabetes (20.6%), only two COPD patients were identified.

medRxiv preprint doi: https://doi.org/10.1101/2020.08.02.20129767; this version posted August 10, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

All patients with diabetes and kidney disease died on admission while more than 80% of the patients with
hypertension died. Out of 425 patients, 75.1% (319) had no documented comorbidity and 76.2% (243) of
them were discharged alive. The Chi-square test results describe the specific comorbidities and survival
outcome to have a statistical significant relationship
Hospital Length of Stay (LOS) was converted from numerical to dummy variable using the
average length of stay (ALOS) which was calculated to be 9 days, all the patients stayed above average
were tagged "A" and those stayed below average tagged "B". Table 2 shows the distribution of the
stratified LOS and survival outcome, among 186 patients stayed above ALOS 180 (96.8%) were
discharged. Death was higher in patients stayed below ALOS, 157 (65.7) out of 239 of them died. The
results can be visualized from Fig. 4 which indicated the longer patient stayed the more likely he is to
survive the disease.

Fig 1: Distribution of age group and survival outcome

Fig 2: Distribution of symptoms and survival outcome
Fig. 3 Distribution of comorbidity (binary) and outcome
Fig. 4 Distribution of length of stay and survival outcome

3.1 Linear Discriminant Analysis
Confusion matrix was utilized to visualize the performance of the machine learning algorithms as
on test data for which the true values are known after building the models using the training set. Confusion
matrix outcome was used to calculate model performance evaluation metrics such as accuracy, precision
and soon.

Table 3: Confusion matrix for LDA

medRxiv preprint doi: https://doi.org/10.1101/2020.08.02.20129767; this version posted August 10, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

Observed classes
Predicted
classes

Table

Died

Discharged

Row Total

Died

30

2

32

Discharged

2

50

52

Column Total

32

52

84

3

represents

the confusion matrix for the LDA model, as it can be seen that the model was able to predict 30 dead
patients correctly and misclassified 2 as discharged, also correctly classified 50 discharged patients and
misclassified 2. The model has an overall classification accuracy of 0.95 (95%).

3.2 Random Forest
Table 4: Confusion matrix for RF
Observed classes
|

Predicted
classes

Died

Discharged

Row Total

Died

32

0

32

Discharged

0

52

52

Column Total

32

52

84

Table 4. showed model performance for the random forest classifier using the confusion matrix.
The model appears to perform perfectly by correctly classifying all 32 dead patients and classified all 52
discharged patients correctly without any misclassification, leading to the overall classification accuracy
of 100% and therefore the error rate is 0%. The importance of each predictor in determining the survival
outcome of CIVID-19 patients with a random forest model was also explored and the result was presented
in Fig. 5, LOS is the most important variable followed by age then symptoms using both Mean Decrease
Accuracy and Mean Decrease Gini. Sex is a less important variable.

Figure 5: plot for variable importance

medRxiv preprint doi: https://doi.org/10.1101/2020.08.02.20129767; this version posted August 10, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

3.3 Support Vector Machine
Table 5: Confusion matrix for SVM
Observed classes
|

Predicted
classes

Died

Discharged

Row Total

Died

30

3

33

Discharged

2

49

51

Column Total

32

52

84

Let's have a look at the results of the performance of the SVM algorithm on the test dataset in
Table 5, in which 30 out of 32 died patients are correctly classified and 2 were misclassified while 49 out
of 52 discharged patients were correctly classified. The overall classification accuracy was 94% and the
apparent error rate of 6%.

3.4 Performance comparison of the models
Table 6. Summary of model performance for the three classifiers
Classifiers
Accuracy Precision
Sensitivity Specificity

F-score

Kappa

AUC

LDA

0.952

0.938

0.938

0.962

0.938

0.899

0.991

RF

1.000

1.000

1.000

1.000

1.000

1.000

0.994

SVM

0.941

0.938

0.909

0.961

0.923

0.875

0.970

We compared the classification accuracy of the three different supervised machine learning
algorithms namely, LDA, RF, and SVM. All of the algorithms performed absolutely well by achieving
greater than 90% accuracy. The recall and precision rates for each of the algorithms also showed a similar
result to that seen with overall accuracy. Table 6 shows the predictive performances of the classifiers for
the test data set. It is observed that RF have better performance on all evaluation metrics: accuracy (100%),

medRxiv preprint doi: https://doi.org/10.1101/2020.08.02.20129767; this version posted August 10, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

precision, recall, specificity, F-score, Kappa and AUC, followed by LDA which also performed very well,
its prediction accuracy has been calculated as 95.2% of accuracy, 93.8% recall, 96.2% specificity, and
89.9% Kappa index. Fig. 7 illustrates the ROC graph for the three classifiers (i.e., LDA, RF, and SVM).
Figure 6 shows three ROC curves for all the three developed models based on the given outcome. RF has
outperformed the other classifiers with an area under the curve(AUC) 0.994. Similarly, LDA and SVM
perform excellently with the area under the curve(AUC) 0.991 and 0.970 respectively.
Figure 6: ROC curve for LDA, RF and SVM on the task of classifying survival outcome of COVID-19
patients

Discussion
This study explored factors influencing survival outcomes of COVID-19 patients. The mean age
of all patients was 53.1 years (the median was 54) which is close to that of data reported by [4] [24] 56.0
years and [10] 57 years , older than 48.9 years reported by [3] and, but younger than that reported by
[11]73 years and [6] 70.6 years. Chi-square test was used to test the associativity between the six predictors
and survival outcome. Table 2 shows the results considering a significant level of 0.05.

Age was

discovered to be highly associated with the survival outcome, it was found that those with older age had
a higher likelihood to die of COVID-19 than those with younger age. the results also indicate
independence between sex and survival outcome. Age has previously reported by many researchers
including [24] [25] [11] to be associated with the death of patients with COVID-19. [25] reported sex not
have significance in determining patientâ€™s outcome. Results of this analysis as displayed in Table 2 shows
that 63.4% (278) of patients reported no symptoms on admission. The most frequent symptoms were acute
respiratory distress, cough, fever and fatigue. [4] [5] [3] highlighted fever, fatigue and dry cough as the
most common COVID-19 symptoms. It is further observed that patient with onset symptoms are more
likely to die of the disease. Also patients with acute respiratory distress and pneumonia are most vulnerable
to severe condition that could lead to death. The finding on patients with morbidity is that out of the 425
patients we studied 108 (25.4%) have reported at least one morbidity on admission and only less than 20%
of them discharged alive. Hypertension (57.5%) and diabetes (20.6%) were the most common underlying

medRxiv preprint doi: https://doi.org/10.1101/2020.08.02.20129767; this version posted August 10, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

diseases and recorded higher mortality rates. These supported the [3] [5] [4] [6] findings. Hospital Length
of Stay (LOS) was found to influence the patient's survival outcome, Table 2 shows that 96.8% of patients
stayed longer than the average length of stay survived. Hence, longer LOS increases the chances of
patients been discharged alive.
The study developed a machine learning techniques for prediction of COVID-19 patient's survival
outcome after a hospital stay, using the patientsâ€™ demographic and clinical characteristics believed to
contributed to the outcomes. Three methods LDA, RF, and SVM were applied on the COVID-19 data set,
our results were presented in Tables 3-5 using a confusion matrix which determines classiï¬ers
performance based on classiï¬ed instances. According to Table 3 LDA correctly classiï¬ed 80 instances out
of 84, yielding accuracy of 95.4%. The performance of RF was presented in Table 4, this algorithm
correctly classiï¬ed all the instances with zero misclassification. Table 5 shows the performance of SVM
algorithms which classiï¬ed 79 instances correctly out of a total number of 84 instances having an accuracy
of 90.9%. From these we can conclude that based on accuracy RF classiï¬er presented a higher
performance in comparison with the others.
The general performances of the models were examined based on seven performance metrics.
consider Table 6, it clearly shown that RF has highest accuracy (100%), recall (100%), precision (1.00)
and specificity (1.00) when comparing with LDA who has Accuracy (0.952), recall (0.938), precision
(0.938) and specificity (0.962) and SVM has Accuracy (0.941), recall (0.909), precision (0.983) and
specificity (0.961), we can clearly see that RF is the best model while LDA is the better then SVM. Based
on the Kappa Statistic which is used to assess the accuracy of any particular measuring cases, RF has the
highest value of 1.00 followed by LDA (0.899) then SVM (0.875). ROC curve represents the combination
of sensitivity and specificity. Theoretically, the area under the ROC (AUC) can assume values between 0
and 1, where an ideal classifier will take the value of 1. However, the practical lower bound for random
classification is 0.5 which means the classifier with no discriminative capability. Whereas classifiers with
an AUC significantly higher than 0.5 have at least some ability to discriminate. the experimental results

medRxiv preprint doi: https://doi.org/10.1101/2020.08.02.20129767; this version posted August 10, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

of the study were displayed in Figure 4 for LDA, RF, and SVM. All the algorithms did well but the AUC
for RF is 0.994, showing the reliability of discriminative capability among all the methods. We can
conclude that both LDA, RF and SVM perform outstandingly. However, the RF algorithm is considered
the best supervised machine learning algorithms of this study.

Conclusions
This paper presents a comparative studies of three machine learning algorithms to predict of the
survival outcomes of COVID-19 patients. The algorithms were evaluated on seven different performance
metrics (accuracy, sensitivity, specificity, and precision, recall, F-measure, ROC and AUC). The results
shown solid prediction capabilities of Machine Learning Techniques in prediction of COVID-19 patients
survival status, all the algorithms performed very well but the RF classifier are considered as best model.
The study also demonstrates that, patients with underline comorbidities and aging patient are more likely
to develop severe situation, and have little chance of surviving COVID-19. In terms of duration of hospital
stay the longer patient stays the higher chance of his surviving. Early detection COVID-19 patients is
essential for identification of vulnerable patients who may need special care to survive the disease, optimal
usage of resources as well as estimation of number of beds required in intensive care units.

References
[1] W. H. Organization, "World Health Organization," 30 April 2020. [Online]. Available:
www.who,int.
[2] World Health Organization, ". Coronavirus Disease 2019 (COVID-19) Situation Report 68," World
Health Organization, 2020.
[3] W.-j. Guan, W.-h. Liang, H.-r. Liang, Z.-s. Chen, Y.-m. Li, X.-q. Liu, R.-c. Chen, C.-l. Tang, T. Wang,
C.-q. Ou, L. Li, . P.-y. Chen, L. Sang and W. Wang, "Comorbidity and its impact on 1590 patients
with COVID-19 in China: a nationwide analysis," Eur Respir J , vol. 55, 2020.

medRxiv preprint doi: https://doi.org/10.1101/2020.08.02.20129767; this version posted August 10, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

[4] D. Wang, , B. HU, C. Hu, F. Zhu, X. Liu, J. Zhang, B. Wang, X. Hui, Z. Cheng, Y. Xiong, Y. Zhao, Y. Li,
X. Wang and Z. Peng, "Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel
Coronavirusâ€“Infected Pneumonia in Wuhan, China," JAMA, vol. 323, no. 1, pp. 1061-1069, 2020.
[5] L. Orioli , M. P. Hermans , J.-P. Thissen, D. Maiter, B. Vandeleene and J.-C. Yombi, "COVID-19 in
diabetic patients: Related risks and specifics of management," Annales dâ€™Endocrinologie, vol. 80,
pp. 101-109, 2020.
[6] C. Leung, "Clinical features of deaths in the novel coronavirus epidemic in China," Rev Med Virol,
2020.
[7] L. Fang, G. Karakiulakis and M. Roth, "Are patients with hypertension and diabetes mellitus at
increased risk for COVID-19 infection?," Elsevier, 2020.
[8] H. Z. ,. Y. Z. ,. X. W. ,. Y. Z. ,. Y. L. ,. W. T. ,. M. Y. ,. X. D. ,. J. Z. ,. R. L. ,. H. L. ,. R. M. E. ,. Y. H. ,. H. N.
,. Y. W. Xiaofan Liu, "Risk Factors Associated with Disease Severity and Length of Hospital Stay in
COVID-19 Patients," Journal of Infection, pp. 1-8, 2020.
[9] F. Zhou, T. Yu, . R. Du, G. Fan, Y. Liu, Z. Liu, J. Xiang, Y. Wang, B. Song, X. Gu, L. Guan, Y. Wei, H. Li,
. X. Wu, J. Xu, S. Tu, Y. Zhang, H. Chen and B. Cao, "Clinical course and risk factors for mortality of
adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study," Lancet, vol. 395,
p. 1054â€“62, 2020.
[10] J.-j. Zhang, X. Dong, Y.-y. Cao, Y.-d. Yuan, Y.-b. Yang, Y.-q. Yan, C. A. Akdis and Y.-d. Gao, "Clinical
characteristics of 140 patients infected with SARSCoV-2 in Wuhan, China," Allergy, p. 00:1â€“12,
2020.
[11] A. B. Docherty, E. M. Harrison, C. A. Green, H. E. Hardwick, R. Pius, L. Norman, K. A. Holden, J. M.
Read, F. Dondelinger, G. Carson, L. Merson, J. Lee, D. Plotkin, L. Sigfrid, S. Halpin, C. Jackson, C.
Gamble, P. W. Horby, J. S. Nguyen-Van-Tam, A. Ho, C. D. Russell, J. Dunning, P. J. Openshaw, . K. J.
Baillie and M. G. Semple, "Features of 20133 UK patients in hospital with covid-19 using the
ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study," BMJ, vol.
369, 2020.
[12] L. Yin, H. Mou, J. Shao, Y. Zhu, X. Pang, J. Yang, J. Zhang, . W. Shi, S. Yu and . H. WangI,
"Correlation between Heart fatty acid binding protein and severe COVID-19: A case-control
study," PLoS ONE, vol. 16, no. 4, 2020.
[13] S. Lalmuanawmaa, J. Hussain and L. Chhakchhuak, "Applications of machine learning and artificial
intelligence for Covid-19 (SARS-CoV-2) pandemic: A review," Chaos, Solitons and Fractals, vol.
139, 2020.

medRxiv preprint doi: https://doi.org/10.1101/2020.08.02.20129767; this version posted August 10, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

[14] S. Uddin, A. Khan, M. E. Hossain and M. M. Ali, "Comparing different supervised machine learning
algorithms for disease prediction," BMC Medical Informatics and Decision Making, vol. 19, no.
281, 2019.
[15] H. Baek, M. Cho, S. Kim, H. Hwang, M. Song and S. Yoo, "Analysis of length of hospital stay using
electronic health records: A statistical and data mining approach," PLoS ONE:, vol. 13, no. 4, 2018.
[16] H. Chown, "A Comparison of Machine Learning Algorithms for the Prediction of Hepatitis C NS3
Protease Cleavage Sites," J Proteomics Bioinform, vol. 12, no. 5, pp. 088-093 , 2019.
[17] S. . L. Anwar, R. Ibrahim, N. Senan and M. Taujuddin, "Application of Data Mining Techniques for
Medical Data Classification: A Review," MATEC Web of Conferences, vol. 150, 2018.
[18] R. Sujath, J. M. Chatterjee and A. . E. Hassanien, "A machine learning forecasting model for
COVID-19 pandemic in India," Stochastic Environmental Research and Risk Assessment, vol. 34, p.
959â€“972, 2020.
[19] R. A. Fisher, "THE USE OF MULTIPLE MEASUREMENTS IN TAXONOMIC PROBLEMS," Annals of
Eugenics, vol. 7, no. 2, pp. 179-188, 1936.
[20] R. C., Radhakrishna , "The Utilization of Multiple Measurements in Problems of Biological
Classification," Journal of the Royal Statistical Society. Series B, vol. 10, no. 2, pp. 159-203, 1948.
[21] L. Breiman, "Random Forests," Machine learning, vol. 45, p. 5â€“32., 2001.
[22] N. Seliya, T. M. Khoshgoftaar and J. Van Hulse, "A Study on the Relationships of Classifier
Performance Metrics," in 21st IEEE International Conference on Tools with Artificial Intelligence,
2009.
[23] T. Fawcett , "An introduction to ROC analysis," Pattern Recogn Lett, vol. 27, no. 8, pp. 861-874,
2006.
[24] W. Zhuo, S. J. John, L. Yang, L. Runyou, Z. Yuxin, C. Xiaoyu, Z. Lun, L. Qian, Z. Yu, Z. Jing, D. Ting, X.
Xinyin, Z. Lijun., H. Jun, D. Yin, Z. Bo and W. Xianping, "Survival analysis of hospital length of stay
of novel coronavirus (COVID-19) pneumonia patients in Sichuan, China," medRxiv, pp. 1-14, 2020.
[25] Q. Ruan, K. Yang, W. Wang, L. Jiang and J. Song, "Clinical predictors of mortality due to COVID-19
based on an analysis of data of 150 patients from Wuhan, China," Intensive Care Med , vol. 46, p.
846â€“848, 2020.
[26] D. D. Richman, R. J. Whitley and F. G. Hayden, Clinical virology, 4th edn., ASM Press: Washington:,
2016..

medRxiv preprint doi: https://doi.org/10.1101/2020.08.02.20129767; this version posted August 10, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

[27] World Health Organization., "Coronavirus Disease 2019 (COVID-19) Situation Report 46," World
Health Organization., 2020.
[28] C. M. Bishop, Pattern Recognition and Machine Learning (Information Science and Statistics).,
Heiddberg, Berlin.: Springer-Verlag, 2006.
[29] A. Ben-Hur, C. Ong , S. Sonnenburg and S. B. Schilkopf, "Support Vector Machines and Kernels for
Computational Biology," Plose Computational Biololgy, vol. 4, 2008.
[30] E. Goel and E. Abhilasha , "Random forest: A review," Int J Adv Res Comput Sci softw Eng, vol. 7,
pp. 251-257., 2017.
[31] Z. Zheng , F. Peng , B. Xu , J. Zhao and H. Liu, "risk factors of critical and mortal COVID-19 cases: A
systematic literature review and meta-analysis," Journal of infection., 2020.
[32] P. Marik, P. Kory and J. Varon, "Does vitamin D status impact mortality from SARS-COV-2
infection?," Medicine in Drug Discovery, 2020.
[33] N. Zhu , D. Zhang and W. Wang , "A Novel Coronavirus from patients with pneumonia in china,"
The New England journal of medicine, vol. 382, no. 8, pp. 727-733, 2020.
[34] L. Li, Z. Yang, Z. Dang, C. Meng, J. Huang, H. Meng, D. Wang, G. Chen, J. Zhang, H. Peng and Y.
Shao, "Propagation analysis and prediction of the COVID-19," Infectious Disease Modelling, vol. 5,
pp. 282-292, 2020.
[35] X. L. F. L. G. Z. C. M. L. W. Zebin Zhao, "Prediction of the COVID-19 spread in African countries and
implications for prevention and controls: A case study in South Africa, Egypt, Algeria, Nigeria,
Senegal and Kenya," Science of the Total Environment, pp. 1-34, 2020.
[36] H.-T. Z. J. G. Y. X. M. W. Y. G. C. S. X. T. L. J. M. Z. X. H. Y. X. H. C. Y. C. T. R. F. W. Y. X. S. H. Li Yan ,
"An interpretable mortality prediction model for COVID-19 patients," nature machine
intelligence, 2020.
[37] S. Y. X. Z. N. W. Q. P. D. L. A. L. Wen Zhao, "Clinical characteristics and durations of hospitalized
patients with COVID-19 in Beijing: a retrospective cohort study," medRxiv, 2020.
[38] A. M. ,. P. G. ,. F. F. ,. A. R. V.-K. U. R. T. R. P. M. A. Sina F. Ardabili, "COVID-19 Outbreak Prediction
with Machine Learning," 2020.
[39] H. M. J. S. Y. Z. X. P. J. Y. J. Z. W. S. S. Y. H. W. Li Yin, "Correlation between Heart fatty acid binding
protein and severe COVID-19: A case-control study," PLOS ONE, vol. 15, no. 4, pp. 1-7, 2020.

medRxiv preprint doi: https://doi.org/10.1101/2020.08.02.20129767; this version posted August 10, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY 4.0 International license .

[40] G. James, D. Witten, . T. Hastie and R. Tibshirani , An Introduction to Statistical Learning, New
York: Springer Science+Business Media, 2013.
[41] M. Mayo, . L. Chepulis and R. G. Paul, "Glycemic-aware metrics and oversampling techniques for
predicting blood glucose levels using machine learning," PLoS ONE , vol. 14, no. 12, 2019.
[42] H. T. Abbas, . L. Alic, M. Erraguntl, . J. X. JiI , M. AbdulGhani, Q. H. Abbasi and M. . K. Qaraqe,
"Predicting long-term type 2 diabetes with support vector machine using oral glucose tolerance
test," PLoS ONE , vol. 14, no. 12, 2019.
[43] M. Ethan, G. David, G. Brian, P. K. and S. Joel, "Using machine learning and an ensemble of
methods to predict kidney transplant survival," PLoS ONE , vol. 14, no. 1, 2019.
[44] A. Manal, A.-M. Mouaz, K. Steven, B. Clinton, E. Jonathan and S. Sherif, "Predicting diabetes
mellitus using SMOTE and ensemble machine learning approach: The Henry Ford ExercIse Testing
(FIT) project," PLoS ONE , vol. 12, no. 7, 2019.
[45] L. Yanhong, L. Zhi, G. Husheng, C. Hongyan, S. Chunying, G. Xingping and Z. Yanbo, "Predicting
congenital heart defects: A comparison of three data mining methods," PLoS ONE, vol. 12, no. 5,
2017.
[46] Y. Liu, Y. Zhou, S. Wen and C. Tang, "A Strategy on Selecting Performance Metrics for Classifier
Evaluation," International Journal of Mobile Computing and Multimedia Communications, vol. 6,
no. 4, pp. 20-35, 2014.
[47] L. A. Jeni, J. F. Cohn and F. De La Torre, "Facing Imbalanced Data Recommendations for the Use of
Performance Metrics," in Int Conf Affect Comput Intell Interact Workshops, 2013.

